Sort   by:  
 Page size 
ProteomicsOligonucleotide catabolism-derived gluconucleosides in C. elegans
Oligonucleotide catabolism-derived gluconucleosides in C. elegans Brian J. Curtis, Tyler J. Schwertfeger, Russell N. Burkhardt, Bennett W. Fox, Jude Andrzejewski, Chester J. J. Wrobel, Jingfang Yu, Pedro R. Rodrigues, Arnaud Tauffenberger*, and Frank C. Schroeder* Boyce Thompson Institute and Depart...
ORGANISM(S): C. Elegans, C. Briggsae, P. Pacificus 
2023-04-26 | MSV000091804 | MassIVE
MetabolomicsGNPS - Modular metabolite assembly in C. elegans depends on carboxylesterases and formation of lysosome-related organelles
Paper title: Modular metabolite assembly in C. elegans depends on carboxylesterases and formation of lysosome-related organelles Author list: Henry H. Le, Chester J. J. Wrobel, Sarah M. Cohen, Jingfang Yu, Heenam Park, Maximilian J. Helf, Brian J. Curtis, Joseph C. Kruempel, Pedro R. Rodrigues, Patr...
ORGANISM(S): Caenorhabditis Elegans (ncbitaxon:6239) 
2020-10-15 | MSV000086293 | GNPS
MetabolomicsGNPS - Microbial and host compensation in a model of leucine breakdown deficiency
Representative MS/MS data for WT and mccc-1 mutant C. elegans reared on Comamonas aquatica. Data in both positive and negative ionization mode, as indicated in the files names. The worm bodies (endo-metabolome) and conditioned media (exo-metabolome) were harvested, extracted, and analyzed separately...
ORGANISM(S): Caenorhabditis Elegans (ncbitaxon:6239) 
2024-01-10 | MSV000093813 | GNPS
ProteomicsERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy
The programmed cell death protein 1 (PD-1) is an inhibitory receptor on T cells and plays an important role in promoting cancer immune evasion. While ubiquitin E3 ligases for regulating PD-1 stability have been reported, deubiquitinase (DUB) governing PD-1 homeostasis to modulate tumor immunotherapy...
ORGANISM(S): Homo Sapiens 
2023-03-17 | PXD040671 |
ProteomicsPlasma proteomics dataset of COVID-19 patients
Quantitative proteomic analysis of plasma from different time courses of fatal, severe, and mild COVID-19 patients was performed to assess the biological changes during treatment.
ORGANISM(S): Homo Sapiens 
2020-06-22 | PXD019106 |
Sort   by:  
 Page size